BioSpace News Archive

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare diseases, announced that Shalini Sharp will step down from her position as Chief Financial Officer and Executive Vice President by September 2, 2020.

Nation’s largest HIV/AIDS organization files brief of amicus curiae with the U.S. Supreme Court in Rutledge v. Pharmaceutical Care Management Association, a pharmacy benefits manager in Arkansas

One-Touch Technology Enhances Remote Patient-Provider Interactions, Enables Practices to Position for COVID-19 Through Flu Season, Improves Access and Timeliness of Care [03-March-2020] ATLANTA , March 3, 2020 /PRNewswire/ -- Over the last week, the CDC and World Health Organization (WHO) have been responding to the outbreak of coronavirus (COVID-19) and the WHO has u

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis, announced that it has raised $100 million in a Series C financing.

REVIVE-HF seeks to demonstrate superiority of the Revivent TC System to current guideline treatment for heart failure

Eureka Therapeutics, Inc. announced that the company is scheduled to present at the following March healthcare conferences

Aldeyra Therapeutics, Inc. announced that David McMullin, Chief Commercial Officer of Aldeyra, will present at Oppenheimer & Co.’s 30th Annual Healthcare Conference in New York City.

Pioneering gene circuit company recruits experienced biopharmaceutical executive to drive clinical development of its novel cell and gene therapy programs

Biodesix, Inc. a leader in lung cancer diagnostics, is extending its blood-based testing portfolio with the release of the Nodify CDTTM test, designed to help physicians identify patients with lung nodules at high risk of lung cancer.

ChemoCentryx, Inc., announced that the Company’s fourth quarter and full year 2019 financial results will be released after market close on Tuesday, March 10, 2020.